Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
ACR Open Rheumatology|June 1, 2021
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory ArthritidesGiovanni Adami, Maurizio Rossini, Ombretta Viapiana, et al.
Rheumatology (Oxford, England)|August 3, 2022
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysisSarah Tosato, Chiara Bonetto, Alice Zanini, et al.
Scientific Reports|October 11, 2023
Changes in bone turnover markers and bone modulators during abatacept treatmentGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
ACR Open Rheumatology|April 9, 2020
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid ArthritisGiovanni Cioffi, Alessandro Giollo, Giovanni Orsolini, et al.
Echocardiography (Mount Kisco, N.Y.)|February 20, 2016
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid ArthritisGiovanni Cioffi, Ombretta Viapiana, Federica Ognibeni, et al.
Advances in Rheumatology (London, England)|September 16, 2021
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritisSara Pezzato, Chiara Bonetto, Cristian Caimmi, et al.
International Journal of Rheumatic Diseases|December 20, 2019
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritisGiovanni Cioffi, Ombretta Viapiana, Giovanni Orsolini, et al.
Rheumatology (Oxford, England)|August 21, 2024
Glucocorticoid sparing effect of Janus kinase inhibitors compared to biologic disease modifying anti-rheumatic drugs in rheumatoid arthritis, a single-centre retrospective analysisGiovanni Adami, Riccardo Bixio, Giulia Virelli, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian studyFederico Aldegheri, Riccardo Bixio, Alessandro Volpe, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life studyRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Pageof 6